Literature DB >> 25637791

Heat shock protein gp96 decreases p53 stability by regulating Mdm2 E3 ligase activity in liver cancer.

Bo Wu1, Xiaoyu Chu1, Cong Feng1, Junwei Hou2, Hongxia Fan2, Ningning Liu2, Changfei Li2, Xianping Kong3, Xin Ye2, Songdong Meng4.   

Abstract

The resistance to apoptosis displayed by liver cancer plays a key role in hepatocarcinogenesis, tumor progression, and resistance to chemo- or radio-therapy. In this study, we uncovered the potential role and mechanism of heat shock protein gp96 in regulating liver tumor cell growth and apoptosis. P53 protein was identified as a gp96 client protein by profiling apoptosis-related proteins in gp96-knockdown liver cancer cells. Overexpression and knockdown studies both demonstrated that gp96 decreases p53 protein levels, and gp96 regulated cell apoptosis in a p53-dependent manner. We further provide evidence that gp96 interacts with both p53 and Mdm2 to enhance Mdm2-mediated p53 ubiquitination and degradation. Moreover, targeting gp96 with siRNA induced cell apoptosis and led to the suppression of liver tumor growth in vivo. In conclusion, we elucidated an underlying mechanism by which gp96 promotes p53 degradation via increasing Mdm2 E3 ligase activity and provided a new therapeutic strategy to target the gp96-mediated anti-apoptotic characteristic of hepatocellular carcinoma.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Apoptosis; Chaperone; Ubiquitination; gp96

Mesh:

Substances:

Year:  2015        PMID: 25637791     DOI: 10.1016/j.canlet.2015.01.034

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  10 in total

Review 1.  Clients and Oncogenic Roles of Molecular Chaperone gp96/grp94.

Authors:  Ephraim A Ansa-Addo; Jessica Thaxton; Feng Hong; Bill X Wu; Yongliang Zhang; Caroline W Fugle; Alessandra Metelli; Brian Riesenberg; Katelyn Williams; Daniel T Gewirth; Gabriela Chiosis; Bei Liu; Zihai Li
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

2.  Blockage of conformational changes of heat shock protein gp96 on cell membrane by a α-helix peptide inhibits HER2 dimerization and signaling in breast cancer.

Authors:  Xin Li; Baozhong Wang; Weiwei Liu; Mingming Gui; Zheng Peng; Songdong Meng
Journal:  PLoS One       Date:  2015-04-21       Impact factor: 3.240

3.  MORC2, a novel oncogene, is upregulated in liver cancer and contributes to proliferation, metastasis and chemoresistance.

Authors:  Zhihong Pan; Qianshan Ding; Qian Guo; Yong Guo; Lianlian Wu; Lu Wu; Meng Tang; Honggang Yu; Fuxiang Zhou
Journal:  Int J Oncol       Date:  2018-03-27       Impact factor: 5.650

4.  Pirh2 mediates the sensitivity of myeloma cells to bortezomib via canonical NF-κB signaling pathway.

Authors:  Li Yang; Jing Chen; Xiaoyan Han; Enfan Zhang; Xi Huang; Xing Guo; Qingxiao Chen; Wenjun Wu; Gaofeng Zheng; Donghua He; Yi Zhao; Yang Yang; Jingsong He; Zhen Cai
Journal:  Protein Cell       Date:  2018-02-13       Impact factor: 14.870

Review 5.  Peptides to combat viral infectious diseases.

Authors:  Shams Al-Azzam; Yun Ding; Jinsha Liu; Priyanka Pandya; Joey Paolo Ting; Sepideh Afshar
Journal:  Peptides       Date:  2020-09-01       Impact factor: 3.750

6.  High Expression of MDM2 and the p53 Protein is Predictive Biomarkers for Poor Prognosis of Oesophageal Squamous Cell Carcinoma.

Authors:  Juan Ye; Lin Zhang; Zhongwen Li; Runduan Lin; Yiling Song; Huanhe Ni; Xiaoxia Gou; Rongzhang Xie
Journal:  Cancer Manag Res       Date:  2021-03-23       Impact factor: 3.989

7.  Hypoxia-Induced Intracellular and Extracellular Heat Shock Protein gp96 Increases Paclitaxel-Resistance and Facilitates Immune Evasion in Breast Cancer.

Authors:  Tian Tian; Jiguang Han; Jian Huang; Shangziyan Li; Hui Pang
Journal:  Front Oncol       Date:  2021-12-20       Impact factor: 6.244

8.  Knockdown of GTPBP4 inhibits cell growth and survival in human hepatocellular carcinoma and its prognostic significance.

Authors:  Wen-Bin Liu; Wei-Dong Jia; Jin-Liang Ma; Ge-Liang Xu; Hang-Cheng Zhou; Yan Peng; Wei Wang
Journal:  Oncotarget       Date:  2017-10-05

9.  The Nrf2/PGC1α Pathway Regulates Antioxidant and Proteasomal Activity to Alter Cisplatin Sensitivity in Ovarian Cancer.

Authors:  Xinyue Deng; Nan Lin; Jiaying Fu; Long Xu; Haoge Luo; Yao Jin; Yanan Liu; Liankun Sun; Jing Su
Journal:  Oxid Med Cell Longev       Date:  2020-11-26       Impact factor: 7.310

Review 10.  Killing by Degradation: Regulation of Apoptosis by the Ubiquitin-Proteasome-System.

Authors:  Ruqaia Abbas; Sarit Larisch
Journal:  Cells       Date:  2021-12-08       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.